Gross Profit Summary of Medistim ASA

Medistim ASA's latest annual gross profit in 2023 was 222.57 Million NOK , down -40.01% from previous year.
Medistim ASA's latest quarterly gross profit in 2024 Q3 was 106.59 Million NOK , down -21.18% from previous quarter.
Medistim ASA reported a annual gross profit of 379.77 Million NOK in annual gross profit 2022, up 18.42% from previous year.
Medistim ASA reported a annual gross profit of 320.7 Million NOK in annual gross profit 2021, up 14.69% from previous year.
Medistim ASA reported a quarterly gross profit of 106.59 Million NOK for 2024 Q3, down -21.18% from previous quarter.
Medistim ASA reported a quarterly gross profit of 56.4 Million NOK for 2024 Q1, up 16.51% from previous quarter.

Annual Gross Profit Chart of Medistim ASA (2023 - 2004)

Historical Annual Gross Profit of Medistim ASA (2023 - 2004)

Year	Gross Profit	Gross Profit Growth
2023	222.57 Million NOK	-40.01%
2022	379.77 Million NOK	18.42%
2021	320.7 Million NOK	14.69%
2020	279.63 Million NOK	1.03%
2019	276.77 Million NOK	13.6%
2018	243.63 Million NOK	9.12%
2017	223.27 Million NOK	12.93%
2016	197.71 Million NOK	6.69%
2015	185.31 Million NOK	16.79%
2014	158.67 Million NOK	12.42%
2013	141.14 Million NOK	6.5%
2012	132.53 Million NOK	12.91%
2011	117.37 Million NOK	2.94%
2010	114.02 Million NOK	-0.05%
2009	114.07 Million NOK	14.46%
2008	99.66 Million NOK	12.13%
2007	88.88 Million NOK	-8.93%
2006	97.59 Million NOK	20.84%
2005	80.76 Million NOK	7.16%
2004	75.36 Million NOK	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	69.69 Million NOK	23.57%
2024 Q3	106.59 Million NOK	-21.18%
2024 Q1	56.4 Million NOK	16.51%
2023 FY	227.83 Million NOK	-40.01%
2023 Q3	101.74 Million NOK	-5.34%
2023 Q4	48.4 Million NOK	-52.42%
2023 Q1	103.36 Million NOK	-0.01%
2023 Q2	107.48 Million NOK	3.99%
2022 Q1	92.44 Million NOK	22.61%
2022 Q3	94.59 Million NOK	5.87%
2022 Q4	103.37 Million NOK	9.28%
2022 FY	379.77 Million NOK	18.42%
2022 Q2	89.35 Million NOK	-3.35%
2021 Q4	75.39 Million NOK	-3.76%
2021 FY	320.7 Million NOK	14.69%
2021 Q2	87.13 Million NOK	9.15%
2021 Q1	79.82 Million NOK	22.76%
2021 Q3	78.34 Million NOK	-10.08%
2020 FY	279.63 Million NOK	1.03%
2020 Q1	80.03 Million NOK	15.94%
2020 Q2	66.59 Million NOK	-16.79%
2020 Q3	67.98 Million NOK	2.09%
2020 Q4	65.02 Million NOK	-4.35%
2019 Q1	68.04 Million NOK	-8.11%
2019 Q2	72.65 Million NOK	6.77%
2019 FY	276.77 Million NOK	13.6%
2019 Q4	69.02 Million NOK	2.94%
2019 Q3	67.05 Million NOK	-7.7%
2018 Q4	74.04 Million NOK	32.01%
2018 Q2	57.61 Million NOK	3.11%
2018 Q1	55.87 Million NOK	-0.66%
2018 FY	243.63 Million NOK	9.12%
2018 Q3	56.09 Million NOK	-2.64%
2017 Q4	56.24 Million NOK	-6.83%
2017 Q2	50.15 Million NOK	-11.24%
2017 FY	223.27 Million NOK	12.93%
2017 Q3	60.37 Million NOK	20.38%
2017 Q1	56.5 Million NOK	24.13%
2016 Q1	49.81 Million NOK	-6.14%
2016 FY	197.71 Million NOK	6.69%
2016 Q4	45.51 Million NOK	-13.32%
2016 Q3	52.51 Million NOK	5.3%
2016 Q2	49.87 Million NOK	0.12%
2015 Q1	40.92 Million NOK	-14.91%
2015 FY	185.31 Million NOK	16.79%
2015 Q4	53.07 Million NOK	10.91%
2015 Q3	47.85 Million NOK	10.08%
2015 Q2	43.46 Million NOK	6.2%
2014 FY	158.67 Million NOK	12.42%
2014 Q4	48.09 Million NOK	22.82%
2014 Q3	39.16 Million NOK	10.17%
2014 Q2	35.54 Million NOK	-0.92%
2014 Q1	35.87 Million NOK	-4.41%
2013 Q4	37.53 Million NOK	14.54%
2013 Q3	32.76 Million NOK	-12.71%
2013 FY	141.14 Million NOK	6.5%
2013 Q2	37.53 Million NOK	12.66%
2013 Q1	33.31 Million NOK	-2.76%
2012 Q2	32.63 Million NOK	0.71%
2012 Q3	33.22 Million NOK	1.8%
2012 Q4	34.26 Million NOK	3.12%
2012 FY	132.53 Million NOK	12.91%
2012 Q1	32.4 Million NOK	19.3%
2011 Q4	27.16 Million NOK	-2.04%
2011 FY	117.37 Million NOK	2.94%
2011 Q2	31.41 Million NOK	1.13%
2011 Q3	27.73 Million NOK	-11.72%
2011 Q1	31.06 Million NOK	2.09%
2010 FY	114.02 Million NOK	-0.05%
2010 Q4	30.42 Million NOK	8.37%
2010 Q3	28.07 Million NOK	-2.77%
2010 Q2	28.88 Million NOK	8.42%
2010 Q1	26.63 Million NOK	2.3%
2009 Q2	27.8 Million NOK	-7.14%
2009 Q1	29.94 Million NOK	0.0%
2009 FY	114.07 Million NOK	14.46%
2009 Q4	26.03 Million NOK	-14.05%
2009 Q3	30.29 Million NOK	8.96%
2008 FY	99.66 Million NOK	12.13%
2007 FY	88.88 Million NOK	-8.93%
2006 FY	97.59 Million NOK	20.84%
2005 FY	80.76 Million NOK	7.16%
2004 FY	75.36 Million NOK	0.0%

Peer Gross Profit Comparison of Medistim ASA

Name	Gross Profit	Gross Profit Difference
Gentian Diagnostics ASA	69.44 Million NOK	-220.515%
Lifecare AS	11.56 Million NOK	-1825.347%

Global Stocks Search

Medistim ASA (MEDI.OL)

Gross Profit Summary of Medistim ASA

Annual Gross Profit Chart of Medistim ASA (2023 - 2004)

Historical Annual Gross Profit of Medistim ASA (2023 - 2004)

Peer Gross Profit Comparison of Medistim ASA